News

European Call for the future Next Generation Sequencing solutions for cancer – open market consultation.

Published on | 5 years ago

Programmes
Health

The oncNGS project

The EU-funded oncNGS project aims to procure the development, testing and implementation of new solutions to address the following challenge: successful implementation in routine clinical care practice of large “cell-free DNA” molecular diagnostics based on NGS technology by providing an integrated, cost-efficient and standardized sequencing and analytical data interpretation and reporting system in various oncology care settings in the EU. More info.

The oncNGS PCP Open Market Consultation

In preparation of the pre-commercial procurement (PCP) call for tender, an Open Market Consultation (OMC) with potential tenderers will be held to broach the views of the market about the scope. All details can be found here.  

The online events will be opened on:

  • 11 may morning 10h am - 12h (CET)
  • 12 may afternoon 16h - 18h (CET)

Prior registration is required and can be done here.

For questions use their contact form.

 

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

2005 articles available search in articles 

Testimonial

image of iCARE4CVD: Thomas More participates in research on improving patient care

iCARE4CVD: Thomas More participates in research on improving patient care

Funded under Horizon Europe’s Innovative Health Initiative (HORIZON-JU-IHI-2022-02-01) and running from 2023 to 2028, the iCARE4CVD project aims to improve patient care across the board, starting from those at risk of developing cardiovascular disease to those with advanced heart failure. Thomas More University of Applied Sciences plays an important role in the project focusing data analysis and AI modeling as well as on the implementation of Patient-Reported Outcome Measures and Patient-Reported Experience Measures. Find out more in the full article.